What to Read in 2026: The Financial Times Guide to Power, Money and the New World Order
What to Read in 2026: Inside the Financial Times’ Big-Idea Book Picks
As 2026 gets underway, the Financial Times has rolled out its annual “What to read” list, a curated guide to books that promise to define the year in ideas, politics, money and storytelling. From the Ozempic-fuelled reshaping of health and finance to sweeping books on power and the new world order—plus new fiction from names like Julian Barnes and Amitav Ghosh—the FT lineup doubles as a reading list and a cultural weather report.
Think of it as a snapshot of what the global elite, policy wonks and serious readers are expected to argue about in 2026: obesity drugs, shifting empires, climate anxiety and the stories we tell to make sense of it all.
Why the FT “What to Read” List Matters in 2026
The Financial Times may be a business paper, but its year-ahead book list has become a kind of cultural barometer. When the FT highlights titles on topics like Ozempic, great-power rivalry or climate migration, it signals what will dominate think-tank panels, book festivals and airport lounge conversations.
- Audience: Global professionals, investors, policy makers and culture-curious readers.
- Focus: Big ideas about economics, geopolitics, technology and their human fallout.
- Blend: Narrative non-fiction, serious policy books and literate, often prize-leaning fiction.
In other words, this is less “beach reads” and more “books that will get quoted in op-eds and at Davos”. The 2026 list leans heavily into three overlapping obsessions: health and pharma power, money and inequality, and the ongoing reshaping of the global order.
“From the Ozempic story to books on power, money and the new world order — plus fiction by Julian Barnes, Amitav Ghosh and others — here are some top titles to look out for in the new year.”
The Ozempic Era: How a Weight-Loss Drug Became a Story About Power and Profit
One of the most eye-catching elements of the FT’s 2026 lineup is its focus on the “Ozempic story”—books exploring the rise of GLP-1 drugs like Ozempic and Wegovy, and the way they are reshaping not just medicine, but markets and culture. Expect a mix of investigative reporting, economic analysis and social commentary.
Books in this lane tend to circle around a few key questions:
- Medical impact: What do GLP-1 drugs actually do, and how transformative are they?
- Economic stakes: How are pharma giants and investors cashing in on a new, recurring-revenue miracle drug?
- Cultural fallout: If weight becomes “treatable” via prescription, what happens to diet culture, body politics and wellness industries?
Framed through the FT lens, the Ozempic story isn’t just medical; it’s a case study in how scientific breakthroughs ricochet through stock markets, insurance systems and global supply chains. These books sit at the intersection of health journalism and financial thriller.
Power and Money: Big-Idea Non-Fiction for a New World Order
The FT has long had a soft spot for “grand narrative” non-fiction—books that promise to explain how power and money really work. In 2026, that instinct converges with a jagged geopolitical moment: US–China rivalry, fraught energy transitions, and a sense that the post-cold-war script has finally broken.
Within that broad frame, the FT’s highlighted books typically fall into a few subgenres:
- Geopolitical diagnostics: analyses of declining US hegemony, Chinese state capitalism, and a resurgent “non-aligned” Global South.
- Economic inequality and oligarchy: narratives about how wealth concentration shapes politics, media and even culture.
- Tech and infrastructure power: works that treat semiconductors, data centers and undersea cables as instruments of statecraft.
Readers of the FT lists tend to want more than hot takes—they look for books that will still feel useful once the current market cycle has turned.
Taken together, these titles trace a clear through-line: anxiety about a fracturing order, and a hunt for frameworks that make sense of polycrisis politics without collapsing into doomscrolling.
New Fiction Highlights: Julian Barnes, Amitav Ghosh and Literary Heavyweights
While the FT is famous for economics and business coverage, its annual list reliably makes room for serious fiction. In 2026, that includes new work from Julian Barnes and Amitav Ghosh—two authors whose names alone tell you this isn’t a light escapist round-up.
While individual plots and settings differ, FT-style fiction picks tend to share a few traits:
- Historical consciousness: Barnes and Ghosh both write with one eye on the past and another on how it warps the present.
- Global scope: Expect cross-border narratives, colonial legacies and characters moving through multiple cultures.
- Ethical ambiguity: These novels are less about moral instruction than about dwelling in complicated, often uncomfortable questions.
In recent years, Ghosh has increasingly woven climate crisis and ecological history into his work; if his new novel follows suit, it will sit neatly alongside the FT’s non-fiction anxiety about climate, migration and resource politics. Barnes, meanwhile, remains a specialist in memory, regret and the slipperiness of truth—precisely the mood of an era negotiating “post-truth” politics.
The Big Themes: Health, Inequality, Climate and the Feeling of Flux
Look past individual titles and a clear pattern emerges. The FT’s “What to read in 2026” list is less about specific news events and more about a mood: a sense that the economic, political and planetary systems we grew up with are in flux, but the replacement order has yet to solidify.
Across genres, several cross-cutting themes stand out:
- Health as a market: Ozempic-era books treat bodies as sites of intense financial and technological experimentation.
- Money as soft power: Geopolitical titles show how sanctions, currency systems and supply chains become tools of influence.
- Climate as narrative: Fiction and non-fiction converge on climate change, not just as a science problem but as a story about justice and memory.
- Identity and legitimacy: Many works probe who gets to speak with authority in an age of fractured media and rising populism.
What’s striking is how many of these 2026 books blur genre lines: economic histories that read like novels, novels that smuggle in climate science, health reporting that doubles as social critique. The FT’s list, intentionally or not, celebrates that hybrid energy.
How to Use the FT 2026 List Without Feeling Overwhelmed
A typical FT “What to read” feature crams in far more titles than most people can realistically get through in a year. The trick is to treat it as a map, not a checklist. Think of the list as clusters of conversations, then pick one or two anchors in each cluster.
A simple strategy:
- Pick a “systems” book: One title on global power, finance or geopolitics that helps you see the big picture.
- Pick a “lived experience” book: Something like the Ozempic story that zooms into how those systems touch real bodies and lives.
- Add one novel: Ideally from the FT fiction picks, to process the same themes emotionally rather than analytically.
That trio—macro analysis, grounded reportage, imaginative fiction—is a manageable way to stay literate in 2026’s debates without turning reading into homework.
Final Take: Reading the FT List as a Guide to the Year Ahead
The FT’s “What to read in 2026” feature is more than a shopping list; it’s a statement about which conversations will matter in the coming months. Ozempic and the politics of the body, the shifting architecture of global power, literary meditations on climate and history—these are not passing fads but long arcs we are only beginning to trace.
If you treat the list less as a command and more as a conversation starter, it becomes a powerful tool: a way to choose a handful of books that will keep you intellectually and culturally in the loop as the year’s headlines unfold. Read selectively, read curiously, and let the FT’s curation be the beginning of your 2026 reading life, not the boundary of it.
For full details, individual titles and FT reviews, visit the official feature on FT.com or explore author and publisher pages via Goodreads and major booksellers.
